Back
iRobot Corp. 10K Form
Buy
53
IRBT
iRobot Corp.
Last Price:
$2.98
Seasonality Move:
1.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | IRBT/iRobot Corp. Quarterly |
| 2023-11-07 | 10Q | IRBT/iRobot Corp. Quarterly |
| 2023-08-08 | 10Q | IRBT/iRobot Corp. Quarterly |
| 2023-05-09 | 10Q | IRBT/iRobot Corp. Quarterly |
| 2022-11-10 | 10Q | IRBT/iRobot Corp. Quarterly |
| 2022-08-10 | 10Q | IRBT/iRobot Corp. Quarterly |
Receive IRBT News And Ratings
See the #1 stock for the next 7 days that we like better than IRBT
IRBT Financial Statistics
Sales & Book Value
| Annual Sales: | $666.4M |
|---|---|
| Cash Flow: | $-47.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.84 |
| Price / Book: | 1.3 |
Profitability
| EPS (TTM): | -6.66280 |
|---|---|
| Net Income (TTM): | $-208.7M |
| Gross Margin: | $130.6M |
| Return on Equity: | -592.84% |
| Return on Assets: | -39.99% |
iRobot Corp. Earnings Forecast
Key iRobot Corp. Financial Ratios
-
The Gross Profit Margin over the past 24 years for IRBT is 19.59%.
-
The Selling, General & Administrative Expenses for IRBT have been equal to 18.27% of Gross Profit Margin.
-
The Research & Development expenses have been 14.00% of Revenue.
-
The Net Earning history of IRBT is -21.84% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 15 years.
iRobot Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Household Durables |
| Sector: | Consumer Discretionary |
| Current Symbol: | IRBT |
| CUSIP: | 462726 |
| Website: | irobot.com |
Debt
| Debt-to-Equity Ratio: | -8.49 |
|---|---|
| Current Ratio: | 0.52 |
| Quick Ratio: | 0.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IRBT Technical Analysis vs Fundamental Analysis
Buy
53
iRobot Corp. (IRBT)
is a Buy
Is iRobot Corp. a Buy or a Sell?
-
iRobot Corp. stock is rated a BuyThe current iRobot Corp. [IRBT] share price is $3.03. The Score for IRBT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.